Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Klaus Pfizenmaier

Showing results (81-90 of 95) with videos related to

Pageof 10
Sort By:
CNS Neuroscience & Therapeutics|April 4, 2019
Continuous infusion of an agonist of the tumor necrosis factor receptor 2 in the spinal cord improves recovery after traumatic contusive injuryMarcus J Gerald, Valerie Bracchi-Ricard, Jerome Ricard, et al.
The Journal of Cell Biology|August 26, 2015
Protein kinase D promotes plasticity-induced F-actin stabilization in dendritic spines and regulates memory formationNorbert Bencsik, Zsófia Szíber, Hanna Liliom, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 5, 2013
Antitumor effects of chimeric receptor engineered human T cells directed to tumor stromaSunitha Kakarla, Kevin K H Chow, Melinda Mata, et al.
Journal of Neuroinflammation|May 3, 2023
Sequential treatment with a TNFR2 agonist and a TNFR1 antagonist improves outcomes in a humanized mouse model for MSValentina Pegoretti, Jan Bauer, Roman Fischer, et al.
Scientific Reports|June 30, 2023
The TNFR1 antagonist Atrosimab reduces neuronal loss, glial activation and memory deficits in an acute mouse model of neurodegenerationNatalia Ortí-Casañ, Ate S Boerema, Karina Köpke, et al.
Cell Death & Disease|April 3, 2020
TNF-Receptor-1 inhibition reduces liver steatosis, hepatocellular injury and fibrosis in NAFLD miceFranziska Wandrer, Stephanie Liebig, Silke Marhenke, et al.
Molecular and Cellular Neurosciences|November 3, 2004
Long-term NR2B expression in the cerebellum alters granule cell development and leads to NR2A down-regulation and motor deficitsKatalin Schlett, Isabelle Pieri, Friedrich Metzger, et al.
Scientific Reports|September 13, 2018
Anti-TNFR1 targeting in humanized mice ameliorates disease in a model of multiple sclerosisSarah K Williams, Richard Fairless, Olaf Maier, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 9, 2019
TNFR2 promotes Treg-mediated recovery from neuropathic pain across sexesRoman Fischer, Maksim Sendetski, Tania Del Rivero, et al.
Brain, Behavior, and Immunity|June 21, 2019
Exogenous activation of tumor necrosis factor receptor 2 promotes recovery from sensory and motor disease in a model of multiple sclerosisRoman Fischer, Tanja Padutsch, Valerie Bracchi-Ricard, et al.
Pageof 10

Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
CNS Neuroscience & Therapeutics|April 4, 2019
Continuous infusion of an agonist of the tumor necrosis factor receptor 2 in the spinal cord improves recovery after traumatic contusive injuryMarcus J Gerald, Valerie Bracchi-Ricard, Jerome Ricard, et al.
The Journal of Cell Biology|August 26, 2015
Protein kinase D promotes plasticity-induced F-actin stabilization in dendritic spines and regulates memory formationNorbert Bencsik, Zsófia Szíber, Hanna Liliom, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 5, 2013
Antitumor effects of chimeric receptor engineered human T cells directed to tumor stromaSunitha Kakarla, Kevin K H Chow, Melinda Mata, et al.
Journal of Neuroinflammation|May 3, 2023
Sequential treatment with a TNFR2 agonist and a TNFR1 antagonist improves outcomes in a humanized mouse model for MSValentina Pegoretti, Jan Bauer, Roman Fischer, et al.
Scientific Reports|June 30, 2023
The TNFR1 antagonist Atrosimab reduces neuronal loss, glial activation and memory deficits in an acute mouse model of neurodegenerationNatalia Ortí-Casañ, Ate S Boerema, Karina Köpke, et al.
Cell Death & Disease|April 3, 2020
TNF-Receptor-1 inhibition reduces liver steatosis, hepatocellular injury and fibrosis in NAFLD miceFranziska Wandrer, Stephanie Liebig, Silke Marhenke, et al.
Molecular and Cellular Neurosciences|November 3, 2004
Long-term NR2B expression in the cerebellum alters granule cell development and leads to NR2A down-regulation and motor deficitsKatalin Schlett, Isabelle Pieri, Friedrich Metzger, et al.
Scientific Reports|September 13, 2018
Anti-TNFR1 targeting in humanized mice ameliorates disease in a model of multiple sclerosisSarah K Williams, Richard Fairless, Olaf Maier, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 9, 2019
TNFR2 promotes Treg-mediated recovery from neuropathic pain across sexesRoman Fischer, Maksim Sendetski, Tania Del Rivero, et al.
Brain, Behavior, and Immunity|June 21, 2019
Exogenous activation of tumor necrosis factor receptor 2 promotes recovery from sensory and motor disease in a model of multiple sclerosisRoman Fischer, Tanja Padutsch, Valerie Bracchi-Ricard, et al.
Pageof 10